Sue DeCotiis, MD - NYC Medical Weight Loss Doctor

Dr. Sue Decotiis operates a physician-led medical weight loss and metabolic health practice in New York, NY, holding triple board certifications from the American Board of Internal Medicine, American Board of Obesity Medicine, and American Academy of Anti-Aging Medicine. Her practice addresses weight management through evidence-based pharmacotherapy and hormone optimization protocols designed for patients experiencing metabolic dysfunction, perimenopause, menopause, and andropause. Dr. Decotiis integrates clinical obesity medicine with functional approaches to metabolic disorders, providing medically supervised programs that address the underlying hormonal and metabolic factors contributing to weight gain and energy decline.

The practice offers FDA-approved GLP-1 receptor agonist therapies including semaglutide and tirzepatide for patients meeting clinical criteria for medical weight loss intervention. These peptide-based medications work by regulating appetite, slowing gastric emptying, and improving insulin sensitivity, and are prescribed as part of comprehensive metabolic programs that include laboratory monitoring, nutritional guidance, and lifestyle modification support. Dr. Decotiis evaluates patients for hormonal imbalances that frequently accompany weight resistance, particularly thyroid dysfunction, insulin resistance, and sex hormone deficiencies that emerge during midlife transitions. Her protocols combine peptide therapy with targeted hormone replacement when clinically indicated, creating individualized treatment plans based on patient-specific metabolic profiles and health objectives.

Dr. Decotiis brings over two decades of clinical experience in internal medicine and obesity medicine to her New York practice, applying her specialized training in anti-aging medicine to address age-related metabolic changes that affect body composition, energy levels, and overall vitality. Her approach involves comprehensive metabolic testing to identify nutritional deficiencies, inflammatory markers, and hormonal imbalances before initiating treatment. Patients receive ongoing medical supervision throughout their programs, with regular follow-up appointments to assess treatment response, adjust medication dosing, and monitor for potential side effects. The practice emphasizes patient education, ensuring individuals understand how their prescribed therapies work and what physiological changes to expect during treatment.

New patients begin with an initial consultation that includes medical history review, current medication assessment, and discussion of weight loss goals and previous treatment attempts. Dr. Decotiis evaluates candidacy for semaglutide or tirzepatide based on BMI, comorbid conditions such as type 2 diabetes or hypertension, and contraindications. The practice provides supplement recommendations tailored to individual nutritional gaps identified through laboratory work, and patients receive guidance on dietary modifications that support peptide therapy outcomes. Follow-up visits occur at regular intervals to track progress, address questions, and modify treatment plans as patients move through different phases of their metabolic transformation.

The practice operates on a hybrid model, offering both in-person appointments at the New York City location and telehealth consultations for established patients who prefer remote access. This flexibility allows patients throughout New York to maintain consistent medical oversight without requiring frequent travel to Manhattan. Dr. Decotiis serves as the primary prescribing physician for all weight loss and hormone optimization protocols, ensuring continuity of care and direct physician involvement in treatment decisions. Her practice attracts patients seeking physician-supervised alternatives to commercial weight loss programs, particularly those with complex medical histories, multiple metabolic conditions, or previous unsuccessful attempts at weight management through diet and exercise alone.